Veterinary PoC Diagnostics Market - Growing demand for pet insurance & increasing pet care expenditure

Overview of This Research:

The study involved four major activities in estimating the size of the global veterinary point-of-care diagnostics market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research.

Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, animal type, and end user). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

Report Objectives:

# To define, describe, and forecast the veterinary point-of-care diagnostics market with respect to segments in product, animal type, application, technology, end user, and region.

# To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).

# To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall veterinary point-of-care diagnostics market.

# To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.

# To forecast the size of the veterinary point-of-care diagnostics market for five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

# To profile the key players in the global veterinary point-of-care diagnostics market and comprehensively analyze their core competencies.

# To track and analyze competitive developments such as acquisitions, new tests/technology developments, geographical expansions, and research & development activities of the leading players in the global veterinary point-of-care diagnostics market.

Global Industry Segmentation:

By technology, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers market in 2018

Based on technology, the market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other technologies. In 2018, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers industry. The higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

By application, the clinical pathology segment accounted for the largest market share in 2018

Based on application, the veterinary point-of-care diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. The clinical pathology segment accounted for the largest market share in 2018. This segment is also projected to register the highest CAGR during the forecast period. The growth in this segment can be attributed to the increasing adoption of chemistry analyzers for the primary diagnosis of diseases in clinics.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=105329994

By end user, the veterinary clinics segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on end user, the market is segmented into veterinary hospitals & academic institutes, veterinary clinics, and home care settings. In 2018, the veterinary clinics segment accounted for the largest share of the market. The large share of this segment is attributed to the growing number of patients visiting vet clinics and the increasing number of private clinical practices.

North America will continue to dominate the market during the forecast period

The market, by region, is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the veterinary point-of-care diagnostics market in 2018. The large share of North America in the global market can be attributed to the increasing adoption of companion animals, growing veterinary healthcare expenditure, and rising demand for animal-derived food products.

Prominent players in the veterinary point-of-care diagnostics market include Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

Read More@ 
https://www.marketsandmarkets.com/Market-Reports/veterinary-poc-diagnostics-market-105329994.html 

Chiral Chromatography Column Market worth $123 million by 2025

Global Growth Boosting Factors:

Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of the market. Moreover, growth opportunities in emerging countries as well as the emergence of green chemistry,is likely to provide opportunities for the chiral chromatography column industry.

Expected Surge in Revenue:

The chiral chromatography column market size is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of 4.5% during the forecast period.

Global Industry Segmentation:

The pharmaceutical&biotechnology companies end-user segment is expected to grow at the highest CAGR from 2020 to 2025.

Pharmaceutical and biotechnology companies are among the key end-users of chiral chromatography columns.Increasing R&D for therapeutic areas, such as cancer, HIV/AIDS, and immunodeficiency disorders, technological innovations in biotechnology research, increasing focus of pharmaceutical and biotechnology companies on extending their product pipeline, rising number of drug discovery and clinical trial projects, and patent expiry of blockbuster drugs and biomolecules are some of the key factors driving the growth of this segment during the forecast period. Additionally, the availability of government and corporate funding for biotechnology and pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are other key factors driving the growth of this segment.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435

Recent Developments: 

# In January 2020, Thermo Fisher entered into an agreement with Astrea Bioseparations to supply EvolveD columns, which include proprietary CaptureSelect and POROS chromatography resins that have been manufactured by Astrea. The columns and resins are used as a part of the molecule purification process to develop biotherapeutics.

# In March 2019, the company introduced the new Thermo Scientific TriPlus 500 Gas Chromatography Headspace Autosampler that provides a scalable, compact design that is reliable, efficient, and capable of handling samples at high-throughput for pharmaceutical, food safety, and environmental scientists performing regulatory-compliant volatile organic compound (VOC) analysis.

# In January 2018, the company introduced FAME GC columns. Agilent J&W DB-FastFAME GC columns feature a mid-content cyanopropyl phase (USP G48). They are engineered for rapid, selective analysis of saturated and polyunsaturated FAMEs, including challenging cis-trans isomers cis-trans isomers.

The metal based segment is expected to grow at the highest CAGR in the chiral chromatography column industry during the forecast period.

The increasing use of HPLC columns in academic institutes as well as in industries where high pressure is employed is likely to drive the market for stainless steel columns in the coming years. Agilent offers the SEC-5 HPLC columns packed with silica particles and coated with a neutral hydrophilic layer, which decreases sample-column interactions and improves peak capacity and resolution. Other prominent players in this market include Thermo Fisher Scientific, Inc., and Merck KGaA. Therefore, the high demand of metal-based columns in the pharmaceutical industry isexpected to emerge as key revenue pockets for the metal-based columns in the chiral chromatography column market.

Key Questions Addressed by the Report:

# The report identifies and addresses the key segments of the chiral chromatography column market, which will help manufacturers and service providers review the growth in demand.

# The report helps system providers understand the pulse of the market and provides insights regarding the drivers, restraints, opportunities, and challenges.

# The report will help key players understand the strategies of their competitors better and make more pivotal strategic decisions.

# The report addresses the market share analysis of key players in the chiral chromatography column market. With the help of this, companies can enhance their revenues in their respective markets.

# The report provides insights about emerging geographies for chiral column sales, and hence, the entire market ecosystem can gain a competitive advantage.

The prepacked column is expected to grow at the highest CAGR during the forecast period.

Prepacked/ready-to-use columns are prefilled with the stationary phase and can directly be attached to chromatographic systems. Prepacked columns exhibit minimal variations and are uniform in nature. These columns are used for early method development for optimizing column packing. These columns are widely used in industries due to their ability to run large amounts of samples on adaily basis. Due to this, prepacked columns dominate the chiral chromatography columns market.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435

Chromatography columns are critical factors to the successful separation of valuable molecules. Pharmaceutical and biotechnology companies are extending their offering of standard, custom, and prepacked columns from lab-scale to pilot and process-scale. Prepacked large-scale columns meet the needs of manufacturing with single-use technologies.

Global Key Players:

To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the chiral chromatography column market. The major players in the chiral chromatography column industry are Agilent Technologies (US), Thermo Fisher Scientific(US), Waters Corporation(US), Daicel Corporation (Japan), Bio-Rad Laboratories(US), W.R.Grace & Co. (US), Merk Group(Germany), GL Sciencies(Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva(US), ES Industruies (US), and Phenomenex  (US)

These players are adopting various strategies to increase their share in the chiral chromatography column market. Contracts & agreements,new product launches, investments and expansions and mergers have been a widely adopted strategy by the major players in the chiral chromatography column industry.

Increasing R&D Expenditure in the Pharma & Biopharma Industry - A Major Boon for the Global Clinical Trial Supplies Market

Overview of This Study:

This study involved four major activities in estimating the current size of the clinical trial supplies market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry have been identified through extensive secondary research

# The revenues generated by leading players operating in the clinical trial supplies market have been determined through primary and secondary research

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

Logistics services segment to dominate the clinical trial supplies market in 2020

Based on service, the clinical trial supplies market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions. The logistics services segment is expected to account for the largest share of this market in 2020, primarily due to the globalization of clinical trials and the increasing number of trials involving temperature-sensitive products.

Recent Developments in the Global Market:

# In December 2019, Catalent launched the New CTSuccess Service to guide sponsors toward smarter clinical trial supply planning.

# In May 2019, Catalent completed the USD 1.2-billion acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies.

# In September 2019, Catalent announced that it would invest USD 9 million in a new clinical supply facility in San Diego, due to open in the summer of 2020.

Phase III segment to register the highest growth in the clinical trial supplies market, by phase

Based on phase, the clinical trial supplies market is segmented into phase I, phase II, phase III, phase IV, and BA/BE studies. The phase III segment is expected to account for the largest share of the clinical trial supplies market in 2020. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the fact that phase III trials are the most expensive, time-consuming, and difficult to design and run.

Key Questions Addressed by the Report:

# Where will all these developments take the industry in the mid-to-long term?
# What are the recent trends affecting the market?
# Who are the key players in the market, and how intense is the competition?
# Which region is a lucrative market for clinical trial supplies?

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059

North America is the largest regional market for clinical trial supplies

The global clinical trial supplies market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. North America is the largest regional market for clinical trial supplies, followed by Europe. The large share of the North American market can primarily be attributed to the presence of well-established CROs and the high and growing R&D expenditure by pharmaceutical and biopharmaceutical companies in the region.

Global Key Players:

The prominent players operating in the global clinical trial supplies market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), and Thermo Fisher Scientific, Inc. (US).

Johnson & Johnson (Ethicon) and Medtronic (Covidien) are the Major Player in the Specimen Retrieval Market

Growth Boosting Factors:

Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment and the removal of specimens from the body, especially laparoscopic procedures. However, the high cost of specimen retrieval systems is a major restraint for this market, particularly in emerging countries.

Revenue Growth Expectations:

The specimen retrieval systems market is expected to reach USD 290 million by 2024 from USD 230 million in 2019, at a CAGR of 4.7%. 

Global Key Players:

The specimen retrieval systems market is highly consolidated in nature, with a few players offering a variety of products. The major players operating in this market are Johnson & Johnson Services, Inc. (US), Teleflex Incorporated (US), Applied Medical Resources Corporation (US), CONMED Corporation (US), Cooper Surgical, Inc. (US), Genicon (US), B. Braun Melsungen AG (Germany), Laprosurge (UK), Purple Surgical (UK), and Medtronic (Ireland). The key growth strategies followed by most companies in the specimen retrieval systems market are acquisitions and agreements. These two strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2018.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126359758

Johnson & Johnson (Ethicon) is the largest player in the specimen retrieval systems market. It has a strong foothold in the specimen retrieval systems market. Ethicon has a strong global distribution network and a good brand reputation among end users. The company’s strong presence and wide distribution channels across the globe have helped it in maintaining its leading position in the specimen retrieval systems market.

Medtronic (Covidien) is a major player in the specimen retrieval systems market. The company operates in four major segments—Cardiac & Vascular Group, Restorative Therapies Group, Minimally Invasive Therapies Group, and Diabetes Group. The company offers the Reliacatch Specimen Retrieval Bag, Endo Catch Gold Specimen Retrieval Pouch, and EndoBag Specimen Retrieval System through its Minimally Invasive Therapies Group. The company offers a wide range of specimen retrieval bags for various introducer sizes and volumes. Moreover, Medtronic’s strong geographical presence has helped it sustain its position in the specimen retrieval systems market.

End Users:

Hospitals were the largest end users of specimen retrieval systems in 2018

By end user, the specimen retrieval systems market is segmented into hospitals and other end users. The hospitals segment accounted for the largest market share in 2018 and is expected to register the highest growth during the forecast period. The large share and high CAGR of this segment can be attributed to the robust infrastructure and presence of skilled professionals in hospitals, which has driven the preference for hospital-based treatment.

North America commanded the largest share of the specimen retrieval systems market in 2018

North America dominates the specimen retrieval systems market. The large share of North America in this market can be attributed to the increasing incidence and prevalence of cancer, hernia, and appendectomy and the availability of reimbursement for laparoscopic surgeries in the region.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=126359758

Transdermal Drug Delivery System Market - Self-Administration and Home Care Drug Delivery Systems

Overview of This Study:

The study involved four major activities to estimate the current market size for transdermal drug delivery systems. Exhaustive secondary research was done to collect information about the market, peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Thirdly, both top-down and bottom-up approaches were employed to estimate the complete market size. Finally, the market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Research Methodologies Followed for This Research:

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the transdermal drug delivery systems market. The primary sources from the demand side include personnel from research organizations, academic institutes, and purchase managers.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203190114

Secondary Research:

In the secondary research process, various secondary sources such as the International Association for the Study of Pain (IASP), International Parkinson and Movement Disorder Society, World Parkinson Congress, International Planned Parenthood Federation (IPPF), International Society of Endocrinology, International Diabetes Federation, International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), European Pain Federation (EFIC), European Society of Contraception and Reproductive Health (ESC), European Society of Cardiology, European Parkinson's Disease Association (EPDA), European Association for the Study of Diabetes (EASD), Asia Pacific Council on Contraception (APCOC), Asian Pacific Society of Cardiology, ASEAN Federation of Endocrine Societies, Guttmacher Institute, National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), United Nations Department of Economic and Social Affairs, directories, industry journals, databases, press releases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

North America is expected to hold the largest market share during the forecast period

North America is one of the major revenue generating regions in the transdermal drug delivery systems market. The transdermal drug delivery systems market in the region is driven by the rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, the increasing use of contraceptives, and the increasing number of research activities related to transdermal drug delivery systems.

Key Market Players:

The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), and GlaxoSmithKline (UK). Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

Key Questions Addressed by the Report:

# Which are the key players in the market and how intense is the competition?
# Emerging countries have immense opportunities for the growth of transdermal drug delivery systems market, will this scenario continue?
# Which product market will dominate in future?
# What does the future look like for transdermal drug delivery systems?
# What are the challenges hindering the adoption of transdermal drug delivery systems?

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=203190114

Medical Equipment Maintenance Market worth $47.49 billion by 2023

The Medical Equipment Maintenance Market is expected to grow from USD 28.97 billion in 2018 to USD 47.49 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period. The growth of this market is mainly driven by the growth in associated equipment markets, rising focus on preventive medical equipment maintenance, adoption of innovative funding mechanism, and the growing purchase of refurbished medical equipment.

Independent Service Organizations (ISOs) segment is expected to grow at the highest CAGR in the medical equipment maintenance market during the forecast period.

Based on the type of service provider, the medical equipment maintenance market is segmented into original equipment manufacturers (OEMs), independent service organizations (ISOs), and in-house maintenance. In 2017, the ISOs segment is expected to grow at the highest CAGR during the forecast period market, primarily due to their advantages, such as better expertise in handling different brands of equipment as opposed to OEMs and the lower cost of services.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69695102

The market for private-sector organizations is expected to grow at the highest CAGR in the medical equipment maintenance market during the forecast period.

On the basis of end user, the medical equipment maintenance market is segmented into public-sector organizations and private-sector organizations. In 2018, private-sector organizations are expected to register the highest CAGR during the forecast period. The increasing number of public-private partnerships is expected to boost the demand for medical equipment maintenance services.

North America is expected to lead the medical equipment maintenance market in 2023

On the basis of the region, the medical equipment maintenance market is segmented into North America, Europe, Asia, and the RoW. In 2018, North America is expected to account for the largest share of the market, followed by Europe, The largest share of the North American market is attributed to the factors such as the rise in aging population and incidence of lifestyle-related diseases, access to quality healthcare, well-established healthcare infrastructure, high adoption of advanced technology, and the presence of prominent players.

In 2018, Europe is expected to hold the second-largest share. Factors such as expanding patient population, rising focus on early diagnosis, growing number of diagnostic imaging procedures, and strategic agreements, partnerships, and collaborations between service providers and end users are expected to fuel market growth in this region.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=69695102

Global Key Players:

The medical equipment maintenance market is highly competitive, with the presence of both OEMs and ISOs. GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Toshiba Medical Systems Europe (Germany), FUJIFILM Holdings Corporation (Japan), Carestream Health, Inc. (U.S.), Agfa-Gevaert Group (Belgium), and Drägerwerk AG & Co. KGaA (Germany) are some of the leading OEMs.

Aramark Services, Inc. (US), BC Technical, Inc. (US), Alliance Medical Group (UK), Althea Group (Italy), Avensys UK Ltd. (UK), and Grupo Empresarial Electromédico (Spain) are some of the leading ISOs operating in the medical equipment maintenance market. 

Most-preferred Strategies Followed by Key Players in the Protein Assays Market to Foster Their Growth

The growth of the protein assays market can be attributed to the increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research.

Global Key Players:

Based on the analysis of strategic developments undertaken by market players between 2014 and 2017, the key strategy followed by most companies in the market is expansions and agreements, partnerships, and collaborations. Some of the leading players that adopted this strategy include Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), Abcam plc. (U.S.), and PerkinElmer Inc. (U.S.).

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547

Thermo Fisher Scientific was leading player in the protein assay products market in 2016. The company focuses on organic and inorganic strategies in order to strengthen its position in the market. In 2015, the company acquired Alfa Aesar (U.S.), and in 2014 acquired Life Technology Corporation (U.S.) these acquisitions helped the company strengthen its protein assays product portfolio.

In 2017, the company acquired Core Informatics (U.S.) and in 2016 acquired Affymetrix (U.S.) in order to enhance its share in the market. In 2016, the company expanded its clinical trials support in Japan. In 2015, the company opened its new clinical services facility in Singapore. These expansions helped the company to amplify its geographic reach.

Target Audience for this Report:

# Protein assay manufacturers and vendors
# Distributors of protein assays
# Various research and consulting companies
# Associations related to pharmaceutical and biotechnological research

Merck KGaA was another leading player in the protein assay products market in 2016. It focuses mainly on collaborations, acquisitions, and expansions to strengthen its position in the market. In November 2015, the company acquired Sigma Aldrich (U.S.). This acquisition helped it to increase its product portfolio and its geographic presence.

The company also focuses on expansions to strengthen its market share. In September 2016, the company expanded its R&D facility in China. This helped the company to increase its protein assays product portfolio. In March 2015, the company collaborated with Illumina (U.S.). This collaboration helped the company to develop assays used in clinical trials.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=93720547

Geographical Growth Scenario:

On the basis of region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The growth in this region is primarily driven by the increasing pharmaceutical and biotechnology R&D expenditure and availability of government funding for life sciences research.